Covered recipient · General Payments record
NATHAN A PENNELL
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$140,845.76
- Reported across 99 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $13,267.50 | 5 |
| Food and Beverage | $261.63 | 6 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Eli Lilly and Company | $5,053.89 | 3 |
| E.R. Squibb & Sons, L.L.C. | $3,517.50 | 1 |
| Janssen Scientific Affairs, LLC | $2,700.00 | 1 |
| Janssen Biotech, Inc. | $2,147.99 | 3 |
| Genentech USA, Inc. | $105.22 | 2 |
| Lilly USA, LLC | $4.53 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $3,517.50 | 03/07/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1101356844 | CMS |
| Eli Lilly and Company | $103.89 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135271827 | CMS |
| Eli Lilly and Company | $1,800.00 | 02/27/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1135266610 | CMS |
| Eli Lilly and Company | $3,150.00 | 02/27/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1135271830 | CMS |
| Genentech USA, Inc. | $33.17 | 02/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133078840 | CMS |
| Genentech USA, Inc. | $72.05 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133078844 | CMS |
| Janssen Biotech, Inc. | $34.30 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078495355 | CMS |
| Janssen Biotech, Inc. | $2,100.00 | 05/17/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1078495237 | CMS |
| Janssen Biotech, Inc. | $13.69 | 11/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078494399 | CMS |
| Janssen Scientific Affairs, LLC | $2,700.00 | 02/07/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1078856680 | CMS |
| Lilly USA, LLC | $4.53 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135221481 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.